INCR
NASDAQ · Pharmaceuticals
Intercure Ltd
$5.31
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+652.4% upside
Low Target
$34.56
Average Target
$39.95
High Target
$63.39
Current Price
$5.31
Current
$5.31
$5.31
Target
$39.95
$39.95
$34.56
$39.95 avg
$63.39
Scenario Analysis
Bear Case
$34.56
550.8%
Low target
Base Case
$39.95
+652.4%
Avg target
Bull Case
$63.39
+1,093.8%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2,783.50
-99.8% from high
52-Week Low
$253.30
+-97.9% from low
Target vs 52W High
$39.95
-98.6% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |